Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
Nanoscale. 2023 Sep 14;15(35):14284-14300. doi: 10.1039/d3nr03016d.
Inflammation is a complex process of the body in response to pathogen infections or dysregulated metabolism, involving the recruitment and activation of immune system components. Repeated dangerous stimuli or uncontrolled immune effector mechanisms can result in tissue injury. Reactive Oxygen Species (ROS) play key roles in physiological cell signaling as well as in the destruction of internalized pathogens. However, aberrant ROS production and release have deleterious effects on the surrounding environment, making ROS regulation a priority to reduce inflammation. Most of the current anti-inflammatory therapies rely on drugs that impair the release of pro-inflammatory mediators. Nevertheless, increasing the enzymatic activity to reduce ROS levels could be an alternative or complementary therapeutic approach to decrease inflammation. Nanozymes are nanomaterials with high catalytic activity that mimic natural enzymes, allowing biochemical reactions to take place. Such functional particles typically show different and regenerable oxidation states or catalytically reactive surfaces offering long-term activity and stability. In this scenario, platinum-based nanozymes (PtNZs) exhibit broad and efficient catalytic functionalities and can reduce inflammation mainly through ROS scavenging, by catalase and superoxide dismutase reactions. Dose-dependent biocompatibility and immune compatibility of PtNZs have been shown in different cells and tissues, both and . Size/shape/surface engineering of the nanozymes could also potentiate their efficacy to act at different sites and/or steps of the inflammation process, such as cytokine removal or specific targeting of activated leukocytes. In the present review, we analyze key inflammation triggering processes and the effects of platinum nanozymes under exemplificative inflammatory conditions. We further discuss potential platinum nanozyme design and improvements to modulate and expand their anti-inflammatory action.
炎症是机体对病原体感染或代谢失调的一种复杂反应过程,涉及免疫系统成分的募集和激活。反复的危险刺激或失控的免疫效应机制可导致组织损伤。活性氧(ROS)在生理细胞信号转导以及内化病原体的破坏中起着关键作用。然而,异常的 ROS 产生和释放对周围环境有有害影响,使 ROS 调节成为减少炎症的首要任务。大多数现有的抗炎疗法依赖于削弱促炎介质释放的药物。然而,增加酶活性以降低 ROS 水平可能是一种替代或补充的治疗方法,以减少炎症。纳米酶是模拟天然酶的具有高催化活性的纳米材料,允许生化反应发生。这些功能性颗粒通常表现出不同的和可再生的氧化态或催化反应表面,提供长期的活性和稳定性。在这种情况下,基于铂的纳米酶(PtNZs)表现出广泛而有效的催化功能,主要通过清除 ROS 、过氧化氢酶和超氧化物歧化酶反应来减少炎症。在不同的细胞和组织中,PtNZs 的剂量依赖性生物相容性和免疫相容性已经得到了证明。纳米酶的尺寸/形状/表面工程也可以增强其在炎症过程的不同部位和/或步骤的功效,例如细胞因子去除或激活白细胞的特异性靶向。在本综述中,我们分析了关键的炎症触发过程和铂纳米酶在典型炎症条件下的作用。我们进一步讨论了潜在的铂纳米酶设计和改进,以调节和扩大其抗炎作用。